These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11110415)

  • 1. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration.
    Anwer K; Kao G; Proctor B; Anscombe I; Florack V; Earls R; Wilson E; McCreery T; Unger E; Rolland A; Sullivan SM
    Gene Ther; 2000 Nov; 7(21):1833-9. PubMed ID: 11110415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions.
    Anwer K; Kao G; Proctor B; Rolland A; Sullivan S
    J Drug Target; 2000; 8(2):125-35. PubMed ID: 10852344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic lipid-based delivery system for systemic cancer gene therapy.
    Anwer K; Meaney C; Kao G; Hussain N; Shelvin R; Earls RM; Leonard P; Quezada A; Rolland AP; Sullivan SM
    Cancer Gene Ther; 2000 Aug; 7(8):1156-64. PubMed ID: 10975676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular electroporation delivery of IFN-alpha gene therapy for inhibition of tumor growth located at a distant site.
    Li S; Zhang X; Xia X; Zhou L; Breau R; Suen J; Hanna E
    Gene Ther; 2001 Mar; 8(5):400-7. PubMed ID: 11313817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration.
    Liu F; Qi H; Huang L; Liu D
    Gene Ther; 1997 Jun; 4(6):517-23. PubMed ID: 9231067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonviral cytokine gene therapy on an orthotopic bladder cancer model.
    Wu Q; Mahendran R; Esuvaranathan K
    Clin Cancer Res; 2003 Oct; 9(12):4522-8. PubMed ID: 14555526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant site.
    Hanna E; Zhang X; Woodlis J; Breau R; Suen J; Li S
    Cancer Gene Ther; 2001 Mar; 8(3):151-7. PubMed ID: 11332985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure.
    Suzuki R; Namai E; Oda Y; Nishiie N; Otake S; Koshima R; Hirata K; Taira Y; Utoguchi N; Negishi Y; Nakagawa S; Maruyama K
    J Control Release; 2010 Mar; 142(2):245-50. PubMed ID: 19883708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination surgery and nonviral interleukin 2 gene therapy for head and neck cancer.
    Li D; Jiang W; Bishop JS; Ralston R; O'Malley BW
    Clin Cancer Res; 1999 Jun; 5(6):1551-6. PubMed ID: 10389944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination therapy of experimental murine hepatoma with mIL-12 gene and MHC I gene mediated by liposome].
    Wang KM; Xia AD; Chen SS
    Ai Zheng; 2002 Oct; 21(10):1041-6. PubMed ID: 12508639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of direct intratumoral gene transfer using cationic lipid-complexed plasmid DNA.
    Clark PR; Stopeck AT; Ferrari M; Parker SE; Hersh EM
    Cancer Gene Ther; 2000 Jun; 7(6):853-60. PubMed ID: 10880015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusogenic activity of vesicular stomatitis virus glycoprotein plasmid in tumors as an enhancer of IL-12 gene therapy.
    Eslahi NK; Muller S; Nguyen L; Wilson E; Thull N; Rolland A; Pericle F
    Cancer Gene Ther; 2001 Jan; 8(1):55-62. PubMed ID: 11219494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective transfer of interleukin-12 gene to solid tumors using a novel gene delivery system, poly [D,L-2,4-diaminobutyric acid].
    Iwashita Y; Ogawa T; Goto S; Nakanishi M; Goto T; Kitano S
    Cancer Gene Ther; 2004 Feb; 11(2):103-8. PubMed ID: 14671674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined IL-2 and IL-12 gene therapy for murine head and neck squamous cell carcinoma.
    Liu S; Yang H; Liang C
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):323-6. PubMed ID: 12408755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct transfer of IL-12 gene into growing Renca tumors.
    Budryk M; Wilczyńska U; Szary J; Szala S
    Acta Biochim Pol; 2000; 47(2):385-91. PubMed ID: 11051203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of SCCVII tumors with systemic chemotherapy and Interleukin-12 gene therapy combination.
    Torrero M; Li S
    Methods Mol Biol; 2008; 423():339-49. PubMed ID: 18370212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies of mouse interleukin-2 gene therapy for head, and neck sequamous cell carcinoma using polycationic liposome-mediated transduction].
    Yang H; Liu S; Liang C; Peng W
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):9-11, 30. PubMed ID: 15600166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model.
    Horiguchi Y; Larchian WA; Kaplinsky R; Fair WR; Heston WD
    Gene Ther; 2000 May; 7(10):844-51. PubMed ID: 10845722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiographically guided utero-placental gene transfer in rabbits with adenoviruses, plasmid/liposomes and plasmid/polyethyleneimine complexes.
    Heikkilä A; Hiltunen MO; Turunen MP; Keski-Nisula L; Turunen AM; Räsänen H; Rissanen TT; Kosma VM; Manninen H; Heinonen S; Ylä-Herttuala S
    Gene Ther; 2001 May; 8(10):784-8. PubMed ID: 11420642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.